Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Corporation (INTC) -- Ignore unavailable to you. Want to Upgrade?

To: BelowTheCrowd who wrote (183427)	2/3/2006 9:18:50 PM
From: Saturn V	Respond to of 186894

the U.S. spent about $25 billion on biomedical research. About $11.5 billion came from the Federal government, with another $3.6 billion of academic not funded by the feds. Industry spent about $10 billion. However, industry R&D is eligible for a tax credit of about 20%, so the government also picked up about $2 billion of the cost of “industry” research. So private industry pays for only about 1/3rd of biomedical R&D. Thanks for posting the statistics. This backs up my assertions in Message 22128096 Thus the the US consumer is subsidizing the health care of the price control countries. I have no problem with other countries getting drugs at US prices. We have to allow pharmacies to import drugs from overseas and get rid of this multiple tier pricing.